TREATMENT OF MILD HYPERTENSION WITH CAPTOPRIL OR CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE - EFFECTS ON BLOOD-PRESSURE AND QUALITY-OF-LIFE

被引:0
作者
ESCOBAR, E
ROESSLER, E
ZARATE, H
ROMAN, O
VALDES, G
MEDINA, E
机构
[1] HOSP DIRECC PREVIS CARABINEROS CHILE, CTR CARDIOVASC, SANTIAGO, CHILE
[2] UNIV CHILE, FAC MED, SANTIAGO, CHILE
[3] CATHOLIC UNIV CHILE, DEPT NEFROL, SANTIAGO, CHILE
[4] UNIV CHILE, ESCUELA SALUD PUBL, SANTIAGO, CHILE
关键词
BLOOD PRESSURE; HIGH; DRUG THERAPY; PROLINE; HYDROCHLOROTHIAZIDE; QUALITY OF LIVE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effects of captopril alone or associated to hydrochlorothiazide on blood pressure and quality of life was studied in 244 hypertensive subjects. After a medication wash out period of 30 days (and 7 additional days when diuretics were used) patients were treated initially with captopril 25 mg b.i.d. (scheme A), if blood pressure was not normalized, hydrochlorothiazide 25 mg o.d was added (scheme B) and the dose of captopril was increased to 50 mg bid (scheme C) in a stepwise fashion. Sixteen patients (6.6%) were lost from follow up; in the rest a significant reduction of blood pressure was obtained at the end of the treatment period (from 163 / 98.9 +/- 19.7 / 3.1 to 143 / 85 +/- 12. 7 / 6. 7 p < 0.05), without changes in cardiac frequency. Using captopril alone, blood pressure was normalized at 15 and 75 days in 62.9 and 70.6% of patients respectively. With captopril plus hydrochlorothiazide blood pressure was normalized in 80.9% of patients. Quality of life improved significantly from of 42.8 +/- 1.7 to 50.7 +/- 15 score points (p < 0.05) secondary effects were observed in 7.4% of patients. It is concluded that captopril alone or associated to hydrochlorothiazide is effective in the treatment of mild hypertension, produces few secondary effects and improves the quality of life.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 31 条
[1]  
Berg G, 1978, INDICATORS VIRUSES W, P1
[2]  
BRAY GA, 1979, STATISTICAL B METROL, V41
[3]   CAPTOPRIL - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE HEART-FAILURE [J].
BROGDEN, RN ;
TODD, PA ;
SORKIN, EM .
DRUGS, 1988, 36 (05) :540-600
[4]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[5]   THE EFFECTS OF ANTIHYPERTENSIVE THERAPY ON THE QUALITY-OF-LIFE [J].
CROOG, SH ;
LEVINE, S ;
TESTA, MA ;
BROWN, B ;
BULPITT, CJ ;
JENKINS, CD ;
KLERMAN, GL ;
WILLIAMS, GH .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) :1657-1664
[6]  
DECESARIS R, 1989, CURR THER RES CLIN E, V46, P587
[7]  
DECESARIS R, 1987, J HYPERTENS S5, V5, pS595
[8]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[9]  
DIVERDI C, 1988, J HYPERTENS, V6, P95
[10]   THE EFFECT OF PRESCRIBED DAILY DOSE FREQUENCY ON PATIENT MEDICATION COMPLIANCE [J].
EISEN, SA ;
MILLER, DK ;
WOODWARD, RS ;
SPITZNAGEL, E ;
PRZYBECK, TR .
ARCHIVES OF INTERNAL MEDICINE, 1990, 150 (09) :1881-1884